Generation of the induced pluripotent stem cell (hiPSC) line (JUFMDOi004-A) from a patient with hearing loss carrying GJB2 (p.V37I) mutation
In this study, we generated induced pluripotent stem cells (iPSC) from peripheral blood mononuclear cells (PBMCs) of patient with homozygous V37I mutation. This iPSC line will be a powerful tool for investigating the pathogenesis and for developing a treatment for GJB2-related hearing loss.
Source: Stem Cell Research - Category: Stem Cells Source Type: research
More News: Audiology | Audiometry | China Health | Deafness | Genetics | Indonesia Health | Japan Health | Malaysia Health | Stem Cell Therapy | Stem Cells | Study | Thailand Health